CPHQ Certified Professional in Healthcare Quality (CPHQ) candidate | http://babelouedstory.com/

CPHQ candidate - Certified Professional in Healthcare Quality (CPHQ) Updated: 2023

Get Full Marks in CPHQ exam with these dumps
Exam Code: CPHQ Certified Professional in Healthcare Quality (CPHQ) candidate June 2023 by Killexams.com team

CPHQ Certified Professional in Healthcare Quality (CPHQ)

The content validity of the CPHQ examination is based on a practice analysis which surveys healthcare quality professionals on the tasks they perform as a part of their job. Each question on the exam links directly to one of the tasks listed in the content outline. Each question is designed to test if the candidate possesses the knowledge necessary to perform the task and/or has the ability to apply it to a job situation.

1. Organizational Leadership (35 items)
A. Structure and Integration
1. Support organizational commitment to quality
2. Participate in organization-wide strategic planning related to quality
3. Align quality and safety activities with strategic goals
4. Engage stakeholders to promote quality and safety (e.g., emergency preparedness, corporate compliance, infection prevention, case management, patient experience, provider network, vendors)
5. Provide consultative support to the governing body and clinical staff regarding their roles and responsibilities (e.g., credentialing, privileging, quality oversight, risk management)
6. Facilitate development of the quality structure (e.g., councils and committees)
7. Assist in evaluating or developing data management systems (e.g., data bases, registries)
8. Evaluate and integrate external best practices (e.g., resources from AHRQ, IHI, NQF, WHO, HEDIS, outcome measures)
9. Participate in activities to identify and evaluate innovative solutions and practices
10. Lead and facilitate change (e.g., change theories, diffusion, spread)
11. Participate in population health promotion and continuum of care activities (e.g., handoffs, transitions of care, episode of care, outcomes, healthcare utilization)
12. Communicate resource needs to leadership to Improve quality (e.g., staffing, equipment, technology)
13. Recognize quality initiatives impacting reimbursement (e.g., pay for performance, value-based contracts)
B. Regulatory, Accreditation, and External Recognition
1. Assist the organization in maintaining awareness of statutory and regulatory requirements (e.g., CMS, HIPAA, OSHA, PPACA)
2. Identify appropriate accreditation, certification, and recognition options (e.g., AAAHC, CARF, DNV GL, ISO, NCQA, TJC, Baldrige, Magnet)
3. Assist with survey or accreditation readiness
4. Participate in the process for evaluating compliance with internal and external requirements for:
a. clinical practice guidelines and pathways (e.g., medication use, infection prevention)
b. service quality
c. documentation
d. practitioner performance evaluation (e.g., peer review, credentialing, privileging)
e. gaps in patient experience outcomes (e.g., surveys, focus groups, teams, grievance, complaints)
f. identification of reportable events for accreditation and regulatory bodies
5. Facilitate communication with accrediting and regulatory bodies Certified Professional in Healthcare Quality Detailed Content Outline1
C. Education, Training, and Communication
1. Design performance, process, and quality improvement training
2. Provide education and training on performance, process, and quality improvement (e.g., including improvement methods, culture change, project and meeting management)
3. Evaluate effectiveness of performance/quality improvement training
4. Develop/provide survey preparation training (e.g., accreditation, licensure, or equivalent)
5. Disseminate performance, process, and quality improvement information within the organization
2. Health Data Analytics (30 items)
A. Design and Data Management
1. Maintain confidentiality of performance/quality improvement records and reports
2. Design data collection plans:
a. measure development (e.g., definitions, goals, and thresholds)
b. tools and techniques
c. sampling methodology
3. Participate in identifying or selecting measures (e.g., structure, process, outcome)
4. Assist in developing scorecards and dashboards
5. Identify external data sources for comparison (e.g., benchmarking)
6. Collect and validate data
B. Measurement and Analysis
1. Use data management systems (e.g., organize data for analysis and reporting)
2. Use tools to display data or evaluate a process (e.g., Pareto chart, run chart, scattergram, control chart)
3. Use statistics to describe data (e.g., mean, standard deviation, correlation, t-test)
4. Use statistical process control (e.g., common and special cause variation, random variation, trend analysis)
5. Interpret data to support decision-making
6. Compare data sources to establish benchmarks
7. Participate in external reporting (e.g., core measures, patient safety indicators, HEDIS bundled payments)
3. Performance and Process Improvement (40 items)
A. Identifying Opportunities for Improvement
1. Facilitate discussion about quality improvement opportunities
2. Assist with establishing priorities
3. Facilitate development of action plans or projects
4. Facilitate implementation of performance improvement methods (e.g., Lean, PDCA, Six Sigma)
5. Identify process champions
Certified Professional in Healthcare Quality
Detailed Content Outline1
B. Implementation and Evaluation
1. Establish teams, roles, responsibilities, and scope
2. Use a range of quality tools and techniques (e.g., fishbone diagram, FMEA, process map)
3. Participate in monitoring of project timelines and deliverables
4. Evaluate team effectiveness (e.g., dynamics, outcomes)
5. Evaluate the success of performance improvement projects
6. Document performance and process improvement results
4. Patient Safety (20 items)
A. Assessment and Planning
1. Assess the organization's culture of safety
2. Determine how technology can enhance the patient safety program (e.g., electronic health record (EHR), abduction/elopement security systems, smart pumps, alerts)
3. Participate in risk management assessment activities (e.g., identification and analysis)
B. Implementation and Evaluation
1. Facilitate the ongoing evaluation of safety activities
2. Integrate safety concepts throughout the organization
3. Use safety principles:
a. human factors engineering
b. high reliability
c. systems thinking
4. Participate in safety and risk management activities related to:
a. incident report review (e.g., near miss and genuine events)
b. sentinel/unexpected event review (e.g., never events)
c. root cause analysis
d. failure mode and effects analysis
Certified Professional in Healthcare Quality (CPHQ)
Healthcare Professional candidate

Other Healthcare exams

CPHQ Certified Professional in Healthcare Quality (CPHQ)
NailTech Nail Technician
RHIA Registered Health Information Administrator (AHIMA RHIA) 2023

If you are interested in successfully completing the CPHQ CPHQ exam to start earning, killexams.com has leading edge developed CPHQ real exam questions that will ensure you pass this CPHQ exam! killexams.com delivers you the most accurate, current and latest updated CPHQ dumps questions and available with a 100% money back guarantee.
Certified Professional in Healthcare(R) Quality (CPHQ)
Question: 155
Which of the following are hardware components that would be included in a
computerized management information system?
A. Binary and decimal coding
B. Flow chart and program
C. Instructions and data
D. Printer and random access memory
Answer: D
Question: 156
Which of the following monitors provides patient outcome information?
A. Nosocomial infection rate
B. Degree of compliance with nursing care documentation
C. Degree of compliance with renewal of antibiotics therapy
D. Equipment malfunction rate
Answer: A
Question: 157
One major difference between traditional quality assurance (QA) and quality
improvement (QI) is that QI:
A. Stresses peer review, while QA focuses on the customer
B. Focuses on the individual, while QA focuses on the process
C. Stresses management by objective, while QA stresses team management
D. Focuses on the process, while QA focuses on individual performance
Answer: D
Question: 158
Measures of central tendency describe the:
A. Typical or middle data point
B. Extent to which the data points are scattered
C. Type and number of classes for dividing the data
D. Average distance of any point in the data set from the mean
Answer: A
Question: 159
The following represents two samples of five hospitals’ hysterectomy rates per 1,000
women aged 40-60 years of age:
Rates Mean Standard Deviation
Sample A 3, 5, 7, 8, 5 5.6 1.8
Sample B 4, 5, 6, 7, 5 5.4 1.1
In analyzing this information, it can be concluded that:
A. demo A has more variability than demo B
B. demo A’s performance is superior to demo B’s
C. There are more cases in demo B
D. There is a data collection error in demo B
Answer: A
Question: 160
The primary benefit of adopting a countrywide or global uniform set of discharge data is
A. Facilitate computerization of data
B. Validate data being collected from other sources
C. Facilitate collection of comparable health information
D. Assist medical records personnel in collecting internal data
Answer: C
Question: 161
I n order to perform a task for which one is held accountable, there must be an equal
balance between responsibility and:
A. Authority
B. Education
C. Delegation
D. Specialization
Answer: A
Question: 162
A patient was in the operating room when a piece of a surgical instrument broke off and
was left in the patient’s body. The patient was readmitted for removal of the foreign
object. Which of the following would most likely apply in this situation?
A. Res ipsa loquitur
B. Contributory negligence
C. Contractual liability
D. Tort liability
Answer: A
Question: 163
Which of the following types of budgets itemizes the major equipment to be purchased in
the next year?
A. Capital
B. Variable
C. Operating
D. Zero-based
Answer: A
Question: 164
A quality manager needs to assign a staff member to assist a medical director in the
development of a quality program for a newly established service. Which of the
following staff members is most appropriate for this project?
A. A newly hired staff member who has demonstrated competence and has time to
complete the task
B. A knowledgeable staff member who works best on defined tasks
C. A motivated staff member who is actively seeking promotion
D. A competent staff member who has good interpersonal skills
Answer: D
Question: 165
A surgeon’s wound infection rate is 32%. Further examination of which of the following
data will provide the most useful information in determining the cause of this surgeon’s
infection rate?
A. Mortality rate
B. Facility infection rate
C. Use of prophylactic antibiotics
D. Type of anesthesia used
Answer: C
Question: 166
The separate services of Pharmacy and Nursing are having difficulty developing an
action plan for medication errors. Pharmacy Services states that Nursing Services causes
the majority of the problems related to errors, while Nursing Services states the opposite.
The quality professional’s role in resolving this problem is to:
A. Provide them with directives on how to solve the problem
B. Facilitate discussion between the groups to enable them to assume ownership of their
portions of the problem
C. Assign the task to an uninvolved manager
D. Refer the problem to the facility wide quality council
Answer: B
Question: 167
Which of the following is most likely to be a benefit of concurrent ambulatory surgical
case review?
A. Decreased medical record review at discharge
B. An increase in the number of cases failing screening criteria
C. An increase in reviewer competence
D. Decreased employee turnover
Answer: A
Question: 168
The primary purpose of an emergency preparedness program is to
A. Conduct evaluations of emergency training
B. Provide evaluations of semiannual evacuation drills
C. Prevent internal disasters that disrupt the facility’s ability to provide care and
D. Manage the consequences of disasters that disrupt the facility’s ability to provide care
Answer: D
Question: 169
According to Joint Commission standards, the safety program must include all of the
following EXCEPT:
A. Monthly safety committee meetings
B. Planned response to natural disasters
C. Orientation and continuing education on safety issues
D. Review of safety policies and procedures for all departments
Answer: A
For More exams visit https://killexams.com/vendors-exam-list
Kill your exam at First Attempt....Guaranteed!

Healthcare Professional candidate - BingNews https://killexams.com/pass4sure/exam-detail/CPHQ Search results Healthcare Professional candidate - BingNews https://killexams.com/pass4sure/exam-detail/CPHQ https://killexams.com/exam_list/Healthcare Search is underway for the next CEO of Maui Health

Maui Memorial Medical Center is seen in February. Search committee members hope to find new CEO to lead Maui Health, which operates Maui Memorial, Kula Hospital and Lanai Cmmunity Hospital, by beginning of next year. — The Maui News / MATTHEW THAYER

Maui Health has hired a top executive search firm to help find its new CEO, whom hospital officials hope could be in place by the beginning of next year.

While it is a “high priority” to find a leader from Hawaii or with Hawaii ties, the chairwoman of Maui Health’s search committee said “our main focus is on finding someone who meets or exceeds the qualifications and key attributes we feel are necessary for a highly successful Maui Health CEO.” 

“This includes someone committed to being an authentic member of the Maui County community, to truly listening and learning, and who would dedicate themselves to addressing the health needs of our islands and people,” Chairwoman Tamar Goodfellow said in an email.

She is a board member at Maui Health and also the president of Maui Health Foundation, an independent, tax-exempt organization that is separate from Maui Health System, according to its website. 

Maui Health, which operates Maui Memorial Medical Center, Kula Hospital and Lanai Community Hospital, is seeking a new CEO since the retirement of Michael Rembis this spring. 

Liz Linares (left), chairwoman of the United Nurses and Health Care Employees of Hawaii, talks to Charmaine Morales, president of the United Nurses Associations of California/Union of Health Care Professionals, based out of California, during a visit to Maui Memorial Medical Center this week. — JACKIE PONCE photo

In the meantime, Kerry Watson, a health care executive from North Carolina, has been serving as interim CEO of Maui Health, a Kaiser Permanente affiliate, since Rembis’ departure. 

His retirement announcement came shortly after rumblings about Rembis being ousted as CEO, but a spokesperson at the time said Rembis’ retirement was unrelated to those claims.

Rembis joined Maui Health in 2017, shortly after the three hospitals transitioned from the state’s public hospital system to the newly created Maui Health System. He dealt with the fallout from the transition and was also at the helm as the COVID-19 pandemic hit. Outbreaks among patients and staff at the hospital spawned criticism from workers and the community who were frustrated over the hospitals’ policies and how they were enforced. Some community members also called for Rembis’ ouster.

While Rembis’ tenure was seen as rocky by some, Maui Health officials credited him at the end of his career for expanding health services, programs and access and having “improved quality metrics that met or exceeded national standards” at Maui Health.

Criticism of Maui Health administration and leadership has continued on, however, and is part of why the search for a new CEO is being watched closely by community members, medical workers and state legislators, as millions of dollars of state funds still get appropriated to Maui Memorial Medical Center. Some Maui state lawmakers have expressed their preference for a new leader also with island ties. 

Liz Linares, chairwoman of the United Nurses and Health Care Employees of Hawaii, said a concern with finding a new CEO is having someone familiar with the culture here on Maui. 

On Thursday, she said she felt she was able to translate that to Watson and to Greg Adams, the chairman and chief executive officer of Kaiser Foundation Health Plan Inc. and Hospitals. A Maui Health spokesperson said on Friday that Adams was at the hospital for a routine visit and it was unrelated to the CEO search. 

“I think they understood that,” Linares said of the request for a new leader sensitive to the island’s differences. She is a case manager at Maui Health.

Linares’ union represents about 850 members at Maui Health, including registered nurses, case managers, radiologists, pharmacists, therapists, admitting staff and receptionists. 

“I think they are seeing the culture here is different and I think that we made it clear today we are worth it and we are valuable and we are worth spending time and money on,” Linares said on Thursday afternoon. 

While Linares and Charmaine Morales, president of the United Nurses Associations of California/Union of Health Care Professionals based out of California, said the main purpose of Thursday was to meet with the leaders as they made their rounds in the hospital, Morales said she will be inquiring more about the CEO search and will seek to make sure the union has input. 

“Ideally if you can get someone from Hawaii, from the islands, that would be ideal. Is it realistic? Probably not. But as long as you get that right fit, it will make the world of difference for this small tight community,” Morales said. 

In a letter this week to Maui County Council members, a group describing themselves as “Citizens for Maui Health,” asked council members to adopt a resolution demanding that the CEO search process be transparent and that the new CEO be “for the people of Maui” and not “a puppet for Kaiser Permanente.” 

The group said it was made up of health care providers at Maui Memorial.

The letter also asked that council members demand Maui Health board members “be aligned to represent Maui.” 

A resolution at the council does not have the force or effect of law, but can express the sentiment of the council. Earlier this year, the council passed a resolution supporting striking United Public Workers union hospital employees and urging Maui Health to resolve contract negotiations.

In April, the union ended a nearly two-month strike after members ratified a new three-year contract with Maui Health. Some of employees’ concerns included new hires making more money than those already working at the hospital, as well as short-staffing and wages. 

The UPW, which represents nearly 500 workers at Maui Health’s three hospitals, said this week it did not have an official position on the CEO search.

The search process began in February with the formation of a six-person search committee from Maui Health’s Board of Directors. 

Goodfellow said the committee includes “four island board members” and two Kaiser Permanente members. Maui Health declined to identify them. 

Maui Health’s Board of Directors includes Goodfellow, Mary Hew, Kathy Lancaster, Kim Horn, Dr. Steve Miller, Dr. Bryan Smith, Clay Sutherland, Tony Takitani and John Yamamoto, according to Maui Health’s website. 

Goodfellow said that in the national search, they have partnered with WittKieffer, a firm that has offices globally and has consultants in many U.S. states. The firm was chosen in part due to its experience working in Hawaii, she said. 

Maui Health declined to say how much they are paying the search firm. 

The search firm has spent the last few months interviewing board members, senior leadership, physician leadership and “other key stakeholders at Maui Health and in the community to develop clear goals, objectives, and priorities for recruiting the ideal candidate.” 

“They have developed a position profile that includes a comprehensive list of qualifications, knowledge and work experience, expectations, and key attributes required for a successful Maui Health CEO,” Goodfellow said. 

The search firm continues to accept nominations, expressions of interest and resumes. 

After candidates are screened, those qualified will be presented to the search committee for review. Top candidates will be identified and interviewed in the following few months, she added. 

“As a standard practice in executive searches, candidate information will remain protected to ensure and respect the confidentiality of the candidate’s interest and other information,” Goodfellow said. 

Maui Health also did not answer a question on who will ultimately decide on the new CEO. They also declined to answer a question about whether union leadership and/or representatives of various positions at the hospital would be privy to the names of finalists for the position. 

While the aim is to have a new leader in place by early next year, Goodfellow said “finding the right candidate is most important and we will work diligently until that is accomplished.”

* Melissa Tanji can be reached at mtanji@mauinews.com.

Today's breaking news and more in your inbox

Sat, 03 Jun 2023 11:08:00 -0500 en-US text/html https://www.mauinews.com/news/local-news/2023/06/search-is-underway-for-the-next-ceo-of-maui-health/
Health Sciences Pre-Professional Program

If you aspire to a career as a physician, physician’s assistant, dentist, optometrist, veterinarian or other health professional, Wilkes University’s Health Sciences Pre-Professional Program can provide the guidance and experiences you need to advance, no matter your academic major.

Program Snapshot

Why Study at Wilkes?

Hands-on research, personalized attention and tailored advising for health sciences students prepare you for the competitive application process and rigors of medical, dental and other professional schools.

Wilkes University has a long tradition of educating students who become health care professionals in a variety of community settings. Our strengths in the sciences and the humanities can make you a competitive candidate for professional schools.

The Health Sciences Program at Wilkes offers you a broad choice professions:

    Medical Laboratory SciencePre-DentalPre-Medical: Allopathic or OsteopathicPre-Occupational TherapyPre-OptometryPre-Physical TherapyPre-Physician AssistantPre-PodiatryPre-Veterinary

More than 90% of students who have strong academic and service records, complete the premedical core, and receive letters of evaluation from the Health Sciences Committee, are accepted into professional schools.

What Will You Gain?

  • You’ll access a team of individuals to help you design your course schedule each semester and guide you through the process of professional school searches, requirements, study guides and admissions exams. This is in addition to your faculty advisor in your academic major.
  • Shadow health care professionals beginning in your freshman year, allowing you to gain health care insight outside the classroom.
  • You’ll be encouraged to participate in poster presentations at regional and national conferences, giving you the unique opportunity to earn publishing credit as an undergraduate student.
  • As a member of the Pre-Professional Society of the College of Science and Engineering, you’ll gain professional development to foster success; this includes biannual seminars to assist with resume preparation, personal statement development, and application preparation.
  • Benefit from connections with organizations offering diverse community service opportunities that not allow you to serve those in need, but will also help Improve interpersonal skills and gain experience that will assist in the preparation for professional school and your career.
  • Take part in networking opportunities with professional schools at the annual Professional/Graduate School Fair.
  • Get to know mentors, including students from Wilkes and affiliated professional schools.
Mon, 22 Aug 2022 11:11:00 -0500 en text/html https://www.wilkes.edu/academics/health-sciences-student-success/health-sciences-pre-professional.aspx
Cornel West Announces Presidential Bid … as a People’s Party Candidate

Cornel West is among the eminent thinkers and voices of our time. Speaking truth to power while synthesizing a politics driven by love and solidarity and care for those you share society with are hallmarks of West’s legacy. And that’s why it is puzzling that he has announced his campaign for president under the banner of the not so aptly named People’s Party.

“In these bleak times, I have decided to run for truth and justice, which takes the form of running for president of the United States as a candidate for the People’s Party,” West announced in a video on Monday. “I enter in the quest for truth, I enter in the quest for justice. And the presidency is just one vehicle to pursue that truth and justice, what I’ve been trying to do all of my life.”

“I come from a tradition where I care about you. I care about the quality of your life, I care about whether you have access to a job with a living wage, decent housing, women having control over their bodies, health care for all, the escalating of the destruction of the planet, the destruction of American democracy. Democracy creates disruption. It creates an eruption. It creates an interruption wide from below, the energies of everyday people is manifest,” West said in trademark fashion.

West, born in Oklahoma before the civil rights era, has been an outspoken voice who has bridged the schools of socialist tradition to Christianity and spiritualism more broadly. He carries a history of fierce advocacy for racial and economic equality, and a strong rejection of blaming material or social misery on the marginalized, as opposed to the elites and structural forces actually responsible.

And he is now running on a party ticket that purports to embrace similar ideals but has had trouble on the execution side of things. While the party began in 2017 with noble roots to form a new political party independent from corporate money and influence, it has been mired in troubling allegations, as well as broader organizational dysfunction.

Numerous sources have corroborated sexual harassment allegations against party founder Nick Brana. Last year, former party member Paula Jean Swearengin told journalists Eoin Higgins and Jordan Chariton that she had witnessed Brana try to force himself onto former party executive director Zana Day, who confirmed the allegations herself. Numerous party board members were apparently forced out for encouraging investigations into the allegations and questioning whether Brana was still fit to lead the party.

“We were removed [from the board] because we were concerned about Nick remaining in his position,” one former board member, Regina Clarke, said. “As the investigation went on, it was clear there was sexual harassment going on; for other alleged acts, there was debate on whether it was harassment or extended further.”

After the allegations were made public, the party’s social media accounts attacked and smeared those questioning the party leadership’s actions.

Other former party volunteers and members have accused the party leadership of lacking democratic organizational processes, having opaque finances, and being generally disrespectful, manifesting sometimes in ableism and racism.

As of now, the People’s Party has ballot access in barely a handful of states. The party’s central website has little direction for those interested in joining the party’s effort to gain ballot access elsewhere, nor to organize and elect candidates on a local level. The policy platform includes six admirable goals, but with little more than a few sentences related to each plank.

West’s decision to run with the party calls into question his instincts, and perhaps even his intentions. It’s not as if he had to run with this party. The Green Party was an option, at least in terms of ballot access. He also could have run as a Democrat, to provide Democratic voters another real option to choose or to put more pressure on Biden to engage with West’s arguments. So too could he have used the party as a vessel to expose even more traditional Democratic voters to his legacy and vision for better politics.

Instead, West is lending credence to an organization that has not earned it, while hamstringing his own electoral potential. In carrying his presidential candidacy through the auspices of the People’s Party, West will have to mobilize a movement and build a political apparatus in the arms of a party that has seldom exhibited a sustained ability to do either.

Mon, 05 Jun 2023 06:25:00 -0500 en-us text/html https://newrepublic.com/post/173244/cornel-west-announces-presidential-bid-peoples-party-candidate
NYC Congressional Candidate Advocates for a Mental Health Moonshot No result found, try new keyword!Patel is also advocating for a fresh approach to tackle mental health, an area where he believes ... who typically wouldn’t get involved in a professional primary campaign. Sun, 06 Nov 2022 07:05:00 -0600 text/html https://health.usnews.com/health-news/blogs/eat-run/articles/nyc-congressional-candidate-advocates-for-a-mental-health-moonshot Telix To Present At Jefferies Healthcare Conference
(MENAFN- PR Newswire) MELBOURNE, Australia, June 5, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that Dr Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies Healthcare Conference being held in New York from June 7 to June 9, 2023.

The presentation will take place on Wednesday June 7 from 12.30pm – 12.55pm EDT (2.30am – 2.55am AEST, June 8).

A live webcast of the presentation will be available at the following link:

The webcast will be accessible on demand on the Telix website following the event.

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with international operations in the United States, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical-stage products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).

Visit for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on twitter (@TelixPharma) and linkedin .

Telix's lead product, gallium-68 (68Ga) gozetotide (also known as 68Ga PSMA-11) injection, has been approved by the U.S. Food and Drug Administration (FDA),[1] and by the Australian Therapeutic Goods Administration (TGA),[2] and by Health Canada.[3] Telix is also progressing marketing authorisation applications for this investigational candidate in the United Kingdom and the European Union.[4]

Telix Investor Relations

Ms. Kyahn Williamson

Telix Pharmaceuticals Limited

SVP Corporate Communications and Investor Relations

Email: [email protected]

Legal Notices

This announcement is not intended as promotion or advertising directed to any healthcare professional or other audience in any country worldwide (including Australia, United States and the United Kingdom). This announcement may include forward-looking statements that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as "may", "expect", "intend", "plan", "estimate", "anticipate", "outlook", "forecast" and "guidance", or other similar words. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our genuine results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on the Company's good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect the Company's business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix's business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix's preclinical and clinical studies, and Telix's research and development programs; Telix's ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals, manufacturing activities and product marketing activities; the commercialisation of Telix's product candidates, if or when they have been approved; estimates of Telix's expenses, future revenues and capital requirements; Telix's financial performance; developments relating to Telix's competitors and industry; and the pricing and reimbursement of Telix's product candidates, if and after they have been approved. Telix's genuine results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Except as required by applicable laws or regulations, Telix does not undertake to publicly update or review any forward-looking statements. Past performance cannot be relied on as a guide to future performance. Readers should read this announcement together with our material risks, as disclosed in our most recently filed reports with the ASX and on our website.

©2023 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals and Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates (all rights reserved).

[1] Telix ASX disclosure 20 December 2021.
Telix ASX disclosure 2 November 2021.
Telix ASX disclosure 14 October 2022.
Telix ASX disclosure 3 April 2023.

SOURCE Telix Pharmaceuticals Limited


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Mon, 05 Jun 2023 14:32:00 -0500 Date text/html https://menafn.com/1106393084/Telix-To-Present-At-Jefferies-Healthcare-Conference
Atlantic Health System Gets $2.75M Grant for Nursing Education

Atlantic Health System (AHS), based in Morristown, New Jersey, is poised to expand and diversify its pipeline of nurses by about 2,000 nursing jobs thanks to a $2.75 million Nursing Expansion Grant it is receiving from the U.S. Department of Labor.

The money will help establish Atlantic Health System’s Pathway to Ensuring Access and Clinical Excellence in Nursing (AHS PEACE), which will create professional pathways for RNs in acute care and critical care specialties, as well as clinical pathways for nursing assistants. Candidates from historically marginalized and underrepresented populations will be included in these positions, according to AHS.

AHS PEACE will support the creation of about 2,000 nursing jobs through the recruitment of graduating high school students, college-level undergraduates, and entry-level incumbent healthcare workers. The program will create partnerships with area colleges and universities, workforce development agencies, and non-profits. 

The grant is one of 25 totaling more than $78 million that the labor department recently awarded to nursing programs in 17 states to address critical staffing challenges and to strengthen and diversify the workforce.

The grant program is a response to the profession’s significant challenges, as the Bureau of Labor Statistics projects an average of 203,200 openings for registered nurses each year through 2031.

“Nurses make up the single, largest group of professional team members at Atlantic Health System and are essential members of the care continuum across all of healthcare,” said Trish O’Keefe PhD, RN, senior vice president, chief nurse executive, Atlantic Health System and president of Morristown Medical Center.

“Nurses have always served on the front lines of care, as a patient’s most direct connection to needed healthcare services,” O’Keefe said. “This program … will help Atlantic Health bolster those front lines while welcoming hundreds of new healthcare workers to the most rewarding career imaginable.”

AHS, a not-for-profit system, offers more than 400 sites of care in New Jersey, Pennsylvania, and the New York metropolitan area, including its seven hospitals.

Carol Davis is the Nursing Editor at HealthLeaders, an HCPro brand.

Tue, 30 May 2023 12:00:00 -0500 en text/html https://www.healthleadersmedia.com/nursing/atlantic-health-system-gets-275m-grant-nursing-education
Better Healthcare AI Stock: Moderna vs. Doximity Better Healthcare AI Stock: Moderna vs. Doximity © Provided by The Motley Fool Better Healthcare AI Stock: Moderna vs. Doximity

When you think of investing in artificial intelligence (AI), technology stocks might come to mind. And plenty of opportunities for AI investing exist there. But there's another area that's also set to stand out in this exciting field. I'm talking about healthcare.

The AI in healthcare market is expected to top $100 billion by the end of the decade, and some companies are already leveraging this technology to advance their work. Two great examples are Moderna (NASDAQ: MRNA) and Doximity (NYSE: DOCS).

If you buy shares today, you may benefit from their game-changing advances down the road. But if you could only buy one right now, which should you go for? 

The case for Moderna

Moderna isn't a novice when it comes to AI. The company already was using AI as it developed its blockbuster coronavirus vaccine. For example, Moderna used AI to generate better messenger RNA sequences -- a basic element needed to develop potential mRNA vaccines or treatments.

Now, though, Moderna is going all in on AI. The company recently inked a deal with International Business Machines (NYSE: IBM) to harness its AI and quantum-computing technologies to help discover new mRNA therapies. Chief executive officer Stéphane Bancel says he expects "breakthrough advances" thanks to quantum computing -- so he wants to invest and prepare now.

Specifically, Moderna will use IBM's MoLFormer to predict the properties of molecules. This will help scientists better understand the potential of certain molecules to prevent or treat disease -- and speed up the development process. Moderna aims to use MoLFormer to help it perfect the lipid nanoparticles that help deliver its mRNA candidates.

Meanwhile, Moderna also is expanding its offices and hiring -- and a lot of this should support its AI ambitions. The new Seattle office will "scale the implementation" of AI, the company said earlier this year.

Drug development generally takes years, and screening molecules can be laborious and costly. If IBM's technology eliminates those problems, this deal -- and AI, in general -- might be a game changer for Moderna.

The case for Doximity

Doximity doesn't discover drugs, but AI could help the company -- and in turn, doctors and patients -- in another way. First, a bit about the company.

Doximity is an online professional network for doctors. It allows them to easily connect with peers, transfer patient files, immediately access research relevant to their specialties, and conduct telemedicine visits. It's basically an online extension of their medical practices.

Doctors don't pay for access to Doximity, but hospital systems and pharmaceutical companies -- those who aim to advertise their products to doctors -- do. It's a worthwhile investment for them since more than 80% of U.S. doctors use the system.

How is Doximity using AI? You've probably heard of the ChatGPT chatbot that's gained a lot of attention in recent times. Well, Doximity is testing its own version, known as DocsGPT.

It's designed to reduce the paperwork that often takes up hours of doctors' days. For example, a doctor can use DocsGPT to write to an insurer for approval to switch a patient's medicine.

Doximity is in the process of getting feedback from doctors to see how DocsGPT can best be used in the medical community. For now, though, it's clear the chatbot can help doctors save valuable time. That may keep them interested in using Doximity -- and that should keep Doximity's advertisers coming back, too.

Moderna or Doximity?

Both companies make good buys today. Doximity has delivered strong earnings growth, and top pharmaceutical customers are spending more and more on the platform. Moderna's generated billions of dollars from its coronavirus vaccine and is on the way to building a blockbuster respiratory vaccine portfolio.

But if I had to choose one company to buy for its involvement in AI, I would go for Moderna. The company is aggressively investing in the area -- and AI could eliminate the biggest challenges drugmakers face today. If AI fulfills its promises, major rewards could lie ahead for Moderna and its investors.


10 stocks we like better than Moderna

When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

They just revealed what they believe are the ten best stocks for investors to buy right now... and Moderna wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks


*Stock Advisor returns as of May 30, 2023


Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Doximity. The Motley Fool recommends Moderna. The Motley Fool has a disclosure policy.

Thu, 01 Jun 2023 21:30:00 -0500 en-US text/html https://www.msn.com/en-us/money/other/better-healthcare-ai-stock-moderna-vs-doximity/ar-AA1c1CyA
Health Experts Reveal the Surprising Benefits of Guava Leaves Guava image © Provided by Getty Images Guava image
Postgraduate Degree in Public and Family Health/Bachelor Degree in Nutrition and Dietetics · 5 years of experience · Brazil

Guava leaves are a source of active chemical compounds such as, saponins, flavonoids, tannins, eugenol and triterpenoids. Guava leaves are commonly used as an herbal tea to treat diarrhea and diabetes. It has an astringent, digestive, diuretic and laxative action. The tea can help in the treatment of diarrhea, digestion disorders, dysentery, enteritis, scurvy, gastrointestinal fermentations, gastroenteritis and urine incontinence. However, it is highly recommended to consult a doctor before start using guava leaves for medicinal purposes.

→ See more questions and expert answers related to Guava.

→ Love Guava? Get nutritional facts, tips from health experts, and more

PhD Candidate (Health Services), Post Graduate Functional Clinical Nutrition, Bachelor's Degree Nutrition and Dietetics · 7 years of experience · Australia

Guava leaves have anti-bacterial properties that help prevent microbial growth, avoiding digestive issues as diarrhea, and can also make the area more alkaline. Catechin, essential antioxidant in guava leaf can also control the blood glucose levels.

→ See more questions and expert answers related to Guava.

→ Love Guava? Get nutritional facts, tips from health experts, and more

Bachelor's degree, Nutrition and Food science · 3 years of experience · Australia

Guava leaves are used to treat skin conditions such as acne and textures issues. They are also used to manage and regulate blood sugar levels.

→ See more questions and expert answers related to Guava.

→ Love Guava? Get nutritional facts, tips from health experts, and more

Mon, 05 Jun 2023 08:30:00 -0500 en-GB text/html https://www.msn.com/en-gb/health/nutrition/health-experts-reveal-the-surprising-benefits-of-guava-leaves/ar-AA19n9jS
Danish PM Frederiksen: I am not a candidate for the job as NATO chief Danish Parliament's Parliament Debate closing debate before the summer holidays, in Copenhagen © Thomson Reuters Danish Parliament's Parliament Debate closing debate before the summer holidays, in Copenhagen

COPENHAGEN (Reuters) - Danish Prime Minister Mette Frederiksen said on Wednesday she is not candidate to replace Jens Stoltenberg, who is due to step down as NATO secretary general later this year.

F-16 jet fighter at Fighter Wing Skrydstrup © Thomson Reuters F-16 jet fighter at Fighter Wing Skrydstrup

"I am not a candidate for the job," she told reporters in Copenhagen.

Speculation about Frederiksen as a serious contender has intensified, after her name first surfaced publicly in a report by Norwegian newspaper VG last month.

(Reporting by Jacob Gronholt-Pedersen; Editing by Jon Boyle)

Tue, 30 May 2023 23:11:40 -0500 en-US text/html https://www.msn.com/en-us/news/other/danish-pm-frederiksen-i-am-not-a-candidate-for-the-job-as-nato-chief/ar-AA1bVRXf

CPHQ information search | CPHQ learn | CPHQ benefits | CPHQ student | CPHQ questions | CPHQ study help | CPHQ teaching | CPHQ benefits | CPHQ information source | CPHQ exam syllabus |

Killexams exam Simulator
Killexams Questions and Answers
Killexams Exams List
Search Exams
CPHQ exam dump and training guide direct download
Training Exams List